OH
Ohad Hammer
Angel InvestorActiveOhad joined Pontifax in 2009 and is involved in identifying as well as evaluating new investment opportunities. Ohad focuses on early-stage ...
Tel Aviv, IsraelFounded 2022
52
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Ohad Hammer.
Investment Thesis & Strategy
Ohad Hammer, as an angel investor, focuses on early-stage opportunities across various industries, seeking to identify and evaluate promising new ventures.
Portfolio Companies
Selected investments from their portfolio of 52 companies
H
HeadSense Medical
Healthcare · Seed, 0
A
ABAC Therapeutics
Biotech · Seed, 0
A
Applied Immune Technologies
Biotech · Seed, 0
M
Metabomed
Biotech · Seed, 0
L
LogicBio Therapeutics
Biotech · Series A, 0
C
Collplant
Biotech · Seed, 0
K
Keros Therapeutics
Biotech · Series A, 0
E
Eyevensys
Biotech · Series B, 0
A
Alizé Pharma
Biotech · Seed, 0
M
MacroCure
Biotech · Seed, 0
c
cCAM Biotherapeutics
Biotech · Seed, 0
F
Fore Biotherapeutics
Biotech · Seed, 0
Frequently Asked Questions
Ohad Hammer focuses on Series B stage investments.